McDermott U - Search Results

1

Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists.

Grinkevitch V, Wappett M, Crawford N, Price S, Lees A, McCann C, McAllister K, Prehn J, Young J, Bateson J, Gallagher L, Michaut M, Iyer V, Chatzipli A, Barthorpe S, Ciznadija D, Sloma I, Wesa A, Tice DA, Wessels L, Garnett M, Longley DB, McDermott U, McDade SS. Grinkevitch V, et al. Among authors: mcdermott u. Mol Cancer Ther. 2022 Apr 1;21(4):594-606. doi: 10.1158/1535-7163.MCT-21-0532. Mol Cancer Ther. 2022. PMID: 35086954 Free PMC article.

2

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Cancer Res. 2002 May 1;62(9):2644-9. Cancer Res. 2002. PMID: 11980662

3

Clinical significance of prognostic and predictive markers in colorectal cancer.

Longley DB, McDermott U, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Pharmacogenomics J. 2002;2(4):209-16. doi: 10.1038/sj.tpj.6500124. Pharmacogenomics J. 2002. PMID: 12196910 Review. No abstract available.

4

Molecular and biochemical markers in colorectal cancer.

McDermott U, Longley DB, Johnston PG. McDermott U, et al. Ann Oncol. 2002;13 Suppl 4:235-45. doi: 10.1093/annonc/mdf665. Ann Oncol. 2002. PMID: 12401696 Free article. Review. No abstract available.

5

Predictive markers for colorectal cancer: current status and future prospects.

Longley DB, McDermott U, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Clin Colorectal Cancer. 2003 Feb;2(4):223-30. doi: 10.3816/CCC.2003.n.003. Clin Colorectal Cancer. 2003. PMID: 12620141 Review.

6

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG. Maxwell PJ, et al. Among authors: mcdermott u. Cancer Res. 2003 Aug 1;63(15):4602-6. Cancer Res. 2003. PMID: 12907638

7

The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.

Longley DB, Allen WL, McDermott U, Wilson TR, Latif T, Boyer J, Lynch M, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Clin Cancer Res. 2004 May 15;10(10):3562-71. doi: 10.1158/1078-0432.CCR-03-0532. Clin Cancer Res. 2004. PMID: 15161716

8

Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.

McDermott U, Longley DB, Galligan L, Allen W, Wilson T, Johnston PG. McDermott U, et al. Cancer Res. 2005 Oct 1;65(19):8951-60. doi: 10.1158/0008-5472.CAN-05-0961. Cancer Res. 2005. PMID: 16204068

9

c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.

Longley DB, Wilson TR, McEwan M, Allen WL, McDermott U, Galligan L, Johnston PG. Longley DB, et al. Among authors: mcdermott u. Oncogene. 2006 Feb 9;25(6):838-48. doi: 10.1038/sj.onc.1209122. Oncogene. 2006. PMID: 16247474

10

Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer.

McLornan DP, Barrett HL, Cummins R, McDermott U, McDowell C, Conlon SJ, Coyle VM, Van Schaeybroeck S, Wilson R, Kay EW, Longley DB, Johnston PG. McLornan DP, et al. Among authors: mcdermott u. Clin Cancer Res. 2010 Jul 1;16(13):3442-51. doi: 10.1158/1078-0432.CCR-10-0052. Epub 2010 Jun 22. Clin Cancer Res. 2010. PMID: 20570920 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page